Wolverine Asset Management’s Haemonetics HAE Stock Holding History

Wolverine Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.5K	Hold	400	–	–	﹤0.01%	1360
2025 Q4	$32.1K	Sell	400 -10,500	-96%	-$705K	﹤0.01%	1327
2025 Q3	$531K	Buy	10,900 +8,100	+289%	+$501K	﹤0.01%	864
2025 Q2	$209K	Buy	+2,800	New	+$185K	﹤0.01%	1021
2024 Q1	–	Sell	-3,300	Closed	-$282K	–	1768
2023 Q4	$282K	Sell	3,300 -11,100	-77%	-$960K	﹤0.01%	988
2023 Q3	$1.29M	Buy	14,400 +4,100	+40%	+$366K	0.01%	658
2023 Q2	$877K	Buy	10,300 +2,000	+24%	+$169K	0.01%	718
2023 Q1	$687K	Buy	8,300 +3,400	+69%	+$275K	0.01%	787
2022 Q4	$385K	Buy	4,900 +1,800	+58%	+$145K	﹤0.01%	1015
2022 Q3	$229K	Buy	+3,100	New	+$223K	﹤0.01%	1205
2021 Q4	–	Sell	-13,600	Closed	-$960K	–	2115
2021 Q3	$960K	Sell	13,600 -10,000	-42%	-$631K	0.01%	742
2021 Q2	$1.57M	Buy	+23,600	New	+$1.67M	0.01%	501

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wolverine Asset Management's HAE Position: Q1 2026 in Review

Wolverine Asset Management opened a new position in Haemonetics (HAE) in Q1 2026: 671 shares worth $37.8K. The stake represents ﹤0.01% of the portfolio and ranks #1298 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in HAE as recently as Q3 2025.

Wolverine Asset Management first reported a position in HAE in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.43M in Q2 2024. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Wolverine Asset Management held 671 shares of Haemonetics worth $37.8K as of Q1 2026.
Haemonetics was a new Wolverine Asset Management position in Q1 2026.
Haemonetics made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1298 holding.
Wolverine Asset Management first reported a position in Haemonetics in Q2 2021 and has held it in 6 quarters since.
Wolverine Asset Management's Haemonetics position peaked at $1.43M in Q2 2024.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.